Abstract

Background: According to WHO, the number of patients with glaucoma in the world ranges from 60.5 to 105 million people, and the number of such patients is also predicted to increase to 80 million. Out of 28 million blind people in the world almost one in five lost their sight due to glaucoma. The aim of this research is to conduct a systematic review of the clinical and economic evidence for the treatment of primary open-angle glaucoma with Tafluprost vs Travoprost. Methods: PubMed interface, MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, NICE databases were used as main searching sources of this study.

How to Cite
F. SHODMANOV, SHAKHNOZA Z. UMAROVA, ZOYA R. USMANOVA, Shoyusuf. Systematic Review of Clinical and Economic Evidence for Primary Open- Angle Glaucoma Therapy with Tafluprost vs Travoprost. Global Journal of Medical Research, [S.l.], apr. 2022. ISSN 2249-4618. Available at: <https://medicalresearchjournal.org/index.php/GJMR/article/view/2668>. Date accessed: 06 july 2022.


Organize Conference

We organize seminars /symposium /conferences/workshop/webinar worldwide on innovative topics and fields of Computer Science and research. We also collaborate, partner or sponsor with a view to provide our professional guidance and expertise to conduct in standard way.

Read More

Research Membership

Global Journals Inc., as described in our Corporate Statement, is an educational, research, research publishing, and professional membership organization. Elevation to the ranks of Fellow of the Association of the Research Society in Computer and Member of the Association of the Research Society in Computer is open.

Read More